Neuroendocrine Tumors of the Kidney: A Single Institution Experience



      Renal NETs, comprised of carcinoid tumors and small cell carcinomas, are a rare group of neoplasms. The rarity of these tumors pose a diagnostic and therapeutic challenge. Our purpose was to characterize the cases treated at a tertiary cancer center and to evaluate patient outcomes with the available treatment modalities.

      Patients and Methods

      This was a retrospective study of patients with renal NETs seen at The University of Texas M.D. Anderson Cancer Center between January 1, 2001, and January 1, 2011. Patient and tumor data were analyzed using descriptive statistical methods.


      Three cases of carcinoid tumors and 6 cases of small cell carcinoma were identified. The median age at diagnosis was 53 years for patients with carcinoid and 65 years for patients with small cell carcinoma. The most common presenting symptoms were back pain, flank pain, and hematuria. The morphological appearance of the tumor cells and their immunohistochemical reactivity for neuroendocrine markers and cytokeratin helped establish the diagnosis. Nephrectomy was the mainstay of treatment for carcinoid tumors, yielding good long-term results, even in the presence of metastases. Surgery and chemotherapy were used for small cell carcinoma of the kidney. The median overall survival for patients with small cell carcinoma of the kidney was 17.3 months.


      Renal carcinoid tumors are indolent and are associated with prolonged survival, and small cell carcinomas of the kidney are aggressive tumors with relatively short overall survival. Although palliative in nature, cytotoxic chemotherapy is the mainstay of therapy and is best given before surgery.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Clinical Genitourinary Cancer
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Klimstra D.S.
        • Modlin I.R.
        • Coppola D.
        • et al.
        The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading and staging systems.
        Pancreas. 2010; 39: 707-712
        • Begin L.R.
        • Guy L.
        • Jacobson S.A.
        • et al.
        Renal carcinoid and horseshoe kidney: a frequent association of two rare entities—a case report and review of the literature.
        J Surg Oncol. 1998; 68: 113-119
        • Quinn A.M.
        • Blackhall F.
        • Wilson G.
        • et al.
        Extrapulmonary small cell carcinoma: a clinicopathological study with identification of potential diagnostic mimics.
        Histopathology. 2012; 61: 454-464
        • Volante M.
        • Birocco N.
        • Gatti G.
        • et al.
        Extrapulmonary neuroendocrine small and large cell carcinomas: a review of controversial diagnostic and therapeutic issues.
        Hum Pathol. 2014; 45: 665-673
        • Walenkamp A.M.
        • Sonke G.S.
        • Sleijfer D.T.
        Clinical and therapeutic aspects of extrapulmonary small cell carcinoma.
        Cancer Treat Rev. 2009; 35: 228-236
        • Têtu B.
        • Ro J.Y.
        • Ayala A.G.
        • et al.
        Small cell carcinoma of the kidney. A clinicopathologic, immunohistochemical, and ultrastructural study.
        Cancer. 1987; 60: 1809-1814
        • Murali R.
        • Kneale K.
        • Lalak N.
        • et al.
        Carcinoid tumors of the urinary tract and prostate.
        Arch Pathol Lab Med. 2006; 130: 1693-1706
        • Guillou L.
        Neuroendocrine carcinoma of the kidney.
        in: Eble J.N. Sauter G. Epstein J.I. Sesterhenn I.A. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours. IARC, Lyon2004: 82
        • Richardson R.L.
        • Weiland L.H.
        Undifferentiated small cell carcinomas in extrapulmonary sites.
        Semin Oncol. 1982; 9: 484-496
        • Hansel D.E.
        • Epstein J.I.
        • Berbescu E.
        • et al.
        Renal carcinoid tumor: a clinicopathologic study of 21 cases.
        Am J Surg Pathol. 2007; 31: 1539-1544
        • Resnick M.E.
        • Unterberger H.
        • McLoughlin P.T.
        Renal carcinoid producing the carcinoid syndrome.
        Med Times. 1966; 94: 895-896
        • Karadeniz-Bilgili M.Y.
        • Semelka R.C.
        • Hyslop W.B.
        • et al.
        MRI findings of primary small-cell carcinoma of kidney.
        Magn Reson Imaging. 2005; 23: 515-517
        • Si Q.
        • Dancer J.
        • Stanton M.L.
        • et al.
        Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases.
        Hum Pathol. 2011; 42: 1792-1798
        • McKeown D.K.
        • Nguyen G.K.
        • Rudrick B.
        • et al.
        Carcinoid of the kidney: radiologic findings.
        Am J Roentgenol. 1988; 150: 143-144
        • Jeung J.A.
        • Cao D.
        • Selli B.W.
        • et al.
        Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings.
        Hum Pathol. 2011; 42: 1554-1561
        • Aung P.P.
        • Killian K.
        • Poropatich C.O.
        • et al.
        Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy.
        Hum Pathol. 2013; 44: 873-880
        • Chuang C.K.
        • Liao S.K.
        A retrospective immunohistochemical and clinicopathological study of small cell carcinomas of the urinary tract.
        Chang Gung Med J. 2003; 26: 26-33
        • Furlan D.
        • Bernasconi B.
        • Uccella S.
        • et al.
        Allelotypes and fluorescence in situ hybridization profiles of poorly-differentiated endocrine carcinomas of different sites.
        Clin Cancer Res. 2005; 11: 1765-1775
        • La Rosa S.
        • Bernasconi B.
        • Micello D.
        • et al.
        Primary small cell neuroendocrine carcinoma of the kidney: morphological, immunohistochemical, ultrastructural, and cytogenetic study of a case and review of the literature.
        Endocr Pathol. 2009; 20: 24-34
        • Tal R.
        • Lask D.M.
        • Livne P.M.
        Metastatic renal carcinoid: case report and review of the literature.
        Urology. 2003; 61: 838
        • Armah H.B.
        • Parwani A.V.
        Primary carcinoid tumor arising within mature teratoma of the kidney: report of a rare entity and review of the literature.
        Diagn Pathol. 2007; 2: 15
        • Chiang M.C.
        • Ou Y.C.
        • Yang C.R.
        • et al.
        Primary renal carcinoid tumor with multiple metastases.
        J Chin Med Assoc. 2010; 73: 435-437
        • Rinke A.
        • Muller H.H.
        • Schade-Brittinger C.
        • et al.
        Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID study group.
        J Clin Oncol. 2009; 27: 4656-4663
        • Korkmaz T.
        • Seber S.
        • Yavuzer D.
        • et al.
        Primary renal carcinoid: treatment and prognosis.
        Crit Rev Oncol Hematol. 2013; 87: 256-264
        • Galanis E.
        • Frytak S.
        • Lloyd R.V.
        Extrapulmonary small cell carcinoma.
        Cancer. 1997; 79: 1729-1736
        • Lee S.Y.
        • Hsu H.H.
        • Lin H.Y.
        • et al.
        Factors associated with the survival of patients with primary small cell carcinoma of the kidney.
        Int J Clin Oncol. 2013; 18: 139-147
        • Majhail N.
        • Elson P.
        • Bukowski R.
        Therapy and outcome of small cell carcinoma of the kidney. Report of two cases and a systematic review of the literature.
        Cancer. 2003; 97: 1436-1441
        • Mackey J.R.
        • Au H.J.
        • Hugh J.
        • et al.
        Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival.
        J Urol. 1998; 159: 1624-1629